Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
Holding ADAP?
Track your performance easily

Adaptimmune Therapeutics (ADAP) Technical Analysis

784 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
2Neutral
13Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Adaptimmune Therapeutics’s (ADAP) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Adaptimmune Therapeutics is a Buy.
Adaptimmune Therapeutics’s (ADAP) 20-Day exponential moving average is 1.12, while Adaptimmune Therapeutics’s (ADAP) share price is $1.05, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 50-Day exponential moving average is 1.13, while Adaptimmune Therapeutics’s (ADAP) share price is $1.05, making it a Sell.

Adaptimmune Therapeutics (ADAP) Pivot Points

Sep 19, 2024, 08:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.98
1.01
1.03
1.06
1.08
1.11
1.13
Fibonacci
1.01
1.03
1.04
1.06
1.08
1.09
1.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Adaptimmune Therapeutics (ADAP) Moving Averages

Sep 19, 2024, 08:52 PM
Period
Simple
Exponential
MA5
1.07Sell
1.06Sell
MA10
1.08Sell
1.09Sell
MA20
1.15Sell
1.12Sell
MA50
1.16Sell
1.13Sell
MA100
1.11Sell
1.12Sell
MA200
1.09Sell
1.03Buy
Adaptimmune Therapeutics’s (ADAP) 10-Day exponential moving average is 1.09, while Adaptimmune Therapeutics’s (ADAP) share price is $1.05, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 100-Day exponential moving average is 1.12, while Adaptimmune Therapeutics’s (ADAP) share price is $1.05, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) stock price is $1.05 and Adaptimmune Therapeutics’s (ADAP) 50-day simple moving average is 1.16, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $1.05 and Adaptimmune Therapeutics’s (ADAP) 100-day simple moving average is 1.11, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $1.05 and Adaptimmune Therapeutics’s (ADAP) 200-day simple moving average is 1.09, creating a Sell signal.

Adaptimmune Therapeutics (ADAP) Technical Indicators

Sep 19, 2024, 08:52 PM
Name
Value
Implied Action
RSI (14)
40.80
Neutral
STOCH (9,6)
10.60
Buy
STOCHRSI (14)
5.69
Buy
MACD (12,26)
-0.03
Buy
ADX (14)
11.51
Buy
Williams %R
-93.33
Buy
CCI (14)
-113.76
Buy
ATR (14)
0.08
-
Ultimate Oscillator
32.46
Neutral
ROC
-14.75
Sell
Adaptimmune Therapeutics’s (ADAP) Relative Strength Index (RSI) is 40.80, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Trend Strength Indicator (ADX) is 11.51, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAP) Commodity Channel Index (CCI) is -113.76, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAP) Price Rate of Change (ROC) is -14.75, creating a Sell signal.

FAQ

Is ADAP a Buy, Hold, or Sell?
Based on ADAP’s technical indicators, ADAP is a Sell.
    What is ADAP’s RSI (14)?
    ADAP’s RSI (14) is 40.80, which suggests ADAP is a Neutral.
      What is ADAP’s MACD?
      ADAP’s MACD is -0.03, which suggests ADAP is a Buy.
        What is ADAP’s 5-day moving average?
        ADAP’s 5-day moving average is 1.07, which suggests ADAP is a Sell.
          What is ADAP’s 20-day moving average?
          ADAP 20-day moving average is 1.15, which suggests ADAP is a Sell.
            What is ADAP’s 50-day moving average?
            ADAP’s 50-day moving average is 1.16, which suggests ADAP is a Sell.
              What is ADAP’s 200-day moving average?
              ADAP’s 200-day moving average is 1.09, which suggests ADAP is a Sell.
                What is ADAP’s Williams % R (14)?
                ADAP’s Williams % R (14) is -93.33, which suggests ADAP is a Buy.
                  What is ADAP’s CCI (14)?
                  ADAP’s CCI (14) is -113.76, which suggests ADAP is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis